The landscape of somatic acquired deletions in cancer cells is shaped by positive and negative selection. Recurrent deletions typically target tumor suppressor, leading to positive selection. Simultaneously, loss of a nearby essential gene can lead to negative selection, and introduce latent vulnerabilities specific to cancer cells. Here we show that, under basic assumptions on positive and negative selection, deletion limitation gives rise to a statistical pattern where the frequency of homozygous deletions decreases approximately linearly between the deletion target gene and the nearest essential genes. Using DNA copy number data from 9,744 human cancer specimens, we demonstrate that linear deletion limitation exists and exposes deletion-...
Identification of cancer driver genes using somatic mutation patterns indicative of positive selecti...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
The landscape of somatic acquired deletions in cancer cells is shaped by positive and negative selec...
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous del...
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous del...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Identification of cancer driver genes using somatic mutation patterns indicative of positive selecti...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
The landscape of somatic acquired deletions in cancer cells is shaped by positive and negative selec...
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous del...
The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous del...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Homozygous deletions are rare in cancers and often target tumour suppressor genes. Here, we build a ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Identification of cancer driver genes using somatic mutation patterns indicative of positive selecti...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...
Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact ...